Poly-γ-d-glutamic acid and protective antigen conjugate vaccines induce functional antibodies against the protective antigen and capsule of bacillus anthracis in guinea-pigs and rabbits

FEMS Immunology and Medical Microbiology

Volumn 57, Issue 2, 2009, Pages 165-172

  Lee, Deog Yong ^a   Chun, Jeong Hoon ^a   Ha, Hyun Joon ^b   Park, Jungchan ^b   Kim, Bong Su ^a   Oh, Hee Bok ^a   Rhie, Gi Eun ^a  

^a Korea National Institute of Health   (South Korea)

^b Hankuk University of Foreign Studies   (South Korea)

Author keywords

Anthrax vaccine; Passive protection; Poly d glutamic acid

Indexed keywords

ANTHRAX VACCINE; BACTERIAL ANTIGEN; FREUND ADJUVANT; NEUTRALIZING ANTIBODY; OVALBUMIN; POLY(GAMMA DEXTRO GLUTAMIC ACID); POLYCLONAL ANTISERUM; PROTECTIVE ANTIGEN; PROTECTIVE ANTIGEN PLUS POLY GAMMA DEXTRO GLUTAMIC ACID CONJUGATE VACCINE; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTHRAX; ANTIBODY PRODUCTION; ARTICLE; BACILLUS ANTHRACIS; BACILLUS LICHENIFORMIS; BACTERIAL SPORE; BACTERIAL VIRULENCE; CONTROLLED STUDY; DRUG CONJUGATION; DRUG EFFICACY; FEMALE; GUINEA PIG; HUMORAL IMMUNITY; IMMUNE RESPONSE; LD 50; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; RABBIT;

ANIMALS; ANTHRAX; ANTHRAX VACCINES; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACILLUS ANTHRACIS; FEMALE; GUINEA PIGS; IMMUNIZATION, PASSIVE; IMMUNOGLOBULIN G; MICE; MICROSCOPY, FLUORESCENCE; POLYGLUTAMIC ACID; RABBITS; RECOMBINANT PROTEINS; VACCINES, CONJUGATE;

EID: 70349655453     PISSN: 09288244     EISSN: 1574695X     Source Type: Journal    
DOI: 10.1111/j.1574-695X.2009.00595.x     Document Type: Article

References (26)

1. Birrer GA, Cromwick A Gross RA (1994) γ-Poly (glutamic acid) formation by Bacillus licheniformis 9945a: physical and biochemical studies. Int J Biol Macromol 16 : 265 275.
2. Brachman PS, Friedlander AM Grabenstein JD (2004) Anthrax vaccine. Vaccines (Plotkin SA Orenstein WA, eds), pp. 887 903. Elsevier, New York.
3. Chabot DJ, Scorpio A, Tobery SA, Little SF, Norris SL Friedlander AM (2004) Anthrax capsule vaccine protects against experimental infection. Vaccine 23 : 43 47.
4. Dixon TC, Meselson M, Guillemin J Hanna PC (1999) Anthrax. New Engl J Med 341 : 815 826.
5. Ezzell JW Welkos SL (1999) The capsule of Bacillus anthracis, a review. J Appl Microbiol 87 : 250.
6. Green BD, Battisti L, Koehler TM, Thorne CB Ivins BE (1985) Demonstration of a capsule plasmid in Bacillus anthracis. Infect Immun 49 : 291 297.
7. Inglesby TV, O'Toole T, Henderson DA et al 2002) Anthrax as a biological weapon. JAMA 287 : 2236 2252.
8. Ivins B, Fellows P, Pitt L, Estep J, Farchaus J, Friedlander A Gibbs P (1995) Experimental anthrax vaccines: efficacy of adjuvants combined with protective antigen against an aerosol Bacillus anthracis spore challenge in guinea pigs. Vaccine 13 : 1779 1784.
9. Ivins BE Welkos SL (1988) Recent advances in the development of an improved human anthrax vaccine. Eur J Epidemiol 4 : 12 19.
10. Joellenbeck LM, Zwanziger LL, Durch JS Strom BL (2002) The Anthrax vaccine: Is it Safe? Does it Work? National Academy Press, Washington, DC.
11. Joyce J, Cook J, Chabot D et al 2006) Immunogenicity and protective efficacy of Bacillus anthracis poly-γ-d-glutamic acid capsule covalently coupled to a protein carrier using a novel triazine-based conjugation strategy. J Biol Chem 281 : 4831 4843.
12. Kobiler D, Gozes Y, Rosenberg H, Marcus D, Reuveny S Altboum Z (2002) Efficiency of protection of guinea pigs against infection with Bacillus anthracis spores by passive immunization. Infect Immun 70 : 544 560.
13. Kozel TR, Thorkildson P, Brandt S, Welch WH, Lovchik JA, AuCoin DP, Vilai J Lyons CR (2007) Protective and immunochemical activities of monoclonal antibodies reactive with the Bacillus anthracis polypeptide capsule. Infect Immun 75 : 152 163.
14. Leppla SH, Robbins JB, Schneerson R Shiloach J (2002) Development of an improved vaccine for anthrax. J Clin Invest 110 : 141 144.
15. Little SF, Ivins BE, Fellows PF Friedlander AM (1997) Passive protection by polyclonal antibodies against Bacillus anthracis infection in guinea pigs. Infect Immun 65 : 5171 5175.
16. Mock M Fouet A (2001) Anthrax. Annu Rev Microbiol 55 : 647 671.
17. Mogridge J, Cunningham K Collier RJ (2002) Stoichiometry of anthrax toxin complexes. Biochemistry 41 : 1079 1082.
18. Phipps AJ, Premanandan C, Barnewall RE Lairmore MD (2004) Rabbit and nonhuman primate models of toxin-targeting human anthrax vaccines. Microbiol Mol Biol R 68 : 617 629.
19. Pozsgay V, Chu C, Pannell L, Wolfe J Robbins JD (1999) Protein conjugates of synthetic saccharides elicit higher levels of serum IgG lipopolysaccharide antibodies in mice than do those of the O-specific polysaccharide from Shigella dysenteriae type 1. P Natl Acad Sci USA 96 : 5194 5197.
20. Reed LJ Muench H (1938) A simple method of estimating fifty percent end points. Am J Hyg 27 : 493 497.
21. Reuveny S, White MD, Adar YY, Kafri Y, Altboum Z, Gozes Y, Kobiler D, Shafferman A Velan B (2001) Search for correlates of protective immunity conferred by anthrax vaccine. Infect Immun 69 : 2888 2893.
22. Rhie GE, Roehrl MH, Mourez M, Collier RJ, Mekalanos JJ Wang JY (2003) A dually active anthrax vaccine that confers protection against both bacilli and toxins. P Natl Acad Sci USA 100 : 10925 10930.
23. Rhie GE, Park YM, Chun JH, Yoo CK, Seong WK Oh HB (2005) Expression and secretion of the protective antigen of Bacillus anthracis in Bacillus brevis. FEMS Immunol Med Mic 45 : 331 339.
24. Ryu C, Lee K, Hawng HJ, Yoo CK, Seong WK Oh HB (2005) Molecular characterization of Korean Bacillus anthracis isolates by amplified fragment length polymorphism analysis and multilocus variable-number tandem repeat analysis. Appl Environ Microb 71 : 4664 4671.
25. Schneerson R, Kubler-Kielb J, Liu TY, Dai ZD, Leppla SH, Yergey A, Backlund P, Shiloach J, Majadly F Robbins JB (2003) Poly (γ-d-glutamic acid) protein conjugates induce IgG antibodies in mice to the capsule of Bacillus anthracis: a potential addition to the anthrax vaccine. P Natl Acad Sci USA 100 : 8945 8950.
26. Turnbull PC (1991) Anthrax vaccines: past, present and future. Vaccine 9 : 533 539.